Skip to main content

Want a detailed portfolio tracker?

Tourmaline Bio (TRML) P/E (2024 - 2026)

Tourmaline Bio (TRML) P/E from Apr 1, 2024 to Jun 3, 2026. The TTM Tourmaline Bio (TRML) P/E is -13.90. You can export chart.

P/E

Annual P/E change of Tourmaline Bio (TRML)

YearP/EChange
2026-13.90N/A
2025-13.90+98.33%
2024-7.01N/A

Comparison Tourmaline Bio (TRML) P/E with competitors

Tourmaline Bio (TRML) P/E is -13.90.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.10-100.74%
ENLVEnlivex Therapeutics Ltd0.15-101.08%
FGENFibroGen Inc0.24-101.73%
FBIOFortress Biotech Inc0.71-105.08%
CHRSCoherus Biosciences Inc0.98-107.03%
ORMPOramed Pharmaceuticals Inc1.47-110.60%
AGENAgenus Inc2.05-114.73%
VIVSVivoSim Labs Inc2.54-118.24%
INVAInnoviva Inc3.19-122.93%
CRMDCorMedix Inc3.65-126.22%
ABEOAbeona Therapeutics Inc4.20-130.24%
VXRTVaxart Inc4.26-130.65%
CVACCureVac N.V.4.45-131.97%
SRPTSarepta Therapeutics Inc4.62-133.26%
GLPGGalapagos NV4.86-134.94%
RIGLRigel Pharmaceuticals4.92-135.38%
ZVRAZevra Therapeutics Inc4.97-135.77%
ABUSArbutus Biopharma Corp5.69-140.95%
CGENCompugen Ltd7.38-153.10%
AUPHAurinia Pharmaceuticals Inc9.25-166.54%
ACADAcadia Pharmaceuticals Inc9.59-168.96%
OMEROmeros Corporation9.88-171.08%
PLXProtalix BioTherapeutics Inc9.91-171.27%
SPROSpero Therapeutics Inc10.73-177.20%
ADMAAdma Biologics Inc11.33-181.49%
SVASinovac Biotech Ltd11.44-182.25%
TBPHTheravance Biopharma Inc11.78-184.70%
HRMYHarmony Biosciences Holdings Inc12.18-187.60%
TGTXTG Therapeutics Inc13.18-194.79%
INCYIncyte Corp13.38-196.24%
SABSSAB Biotherapeutics Inc14.06-201.10%
XOMAXOMA Corp14.95-207.49%
REGNRegeneron Pharmaceuticals Inc14.98-207.74%
PBYIPuma Biotechnology Inc15.05-208.24%
EXELExelixis Inc15.79-213.60%
NAGENiagen Bioscience Inc16.35-217.62%
CPRXCatalyst Pharmaceuticals Inc17.34-224.74%
MDXGMimedx Group Inc17.38-224.96%
ARGXArgen X SE23.07-265.93%
HALOHalozyme Therapeutics Inc23.20-266.86%
XOMAOXOMA Corp25.34-282.28%
VRTXVertex Pharmaceuticals Inc25.66-284.52%
XOMAPXOMA Corp25.67-284.62%
CTMXCytomX Therapeutics Inc25.70-284.82%
ASNDAscendis Pharma A/S26.35-289.54%
RPRXRoyalty Pharma plc - Class A27.50-297.75%
SLNOSoleno Therapeutics Inc29.02-308.68%
LGNDLigand Pharmaceuticals Inc - Class B30.19-317.10%
BMRNBiomarin Pharmaceutical Inc37.51-369.75%
APLSApellis Pharmaceuticals Inc39.02-380.64%
KRYSKrystal Biotech Inc39.70-385.50%
GMABGenmab40.20-389.14%
ONCBeiGene Ltd67.03-582.06%
TECHBio-Techne Corp68.59-593.34%
VCELVericel Corp80.63-679.89%
PHARPharming Group N.V.87.74-731.03%
ALNYAlnylam Pharmaceuticals Inc124.93-998.52%
TLXTelix Pharmaceuticals Ltd139.89-1106.09%
CORTCorcept Therapeutics Inc158.39-1239.14%